http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32197320

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 821
issn 1522-1946
1522-726X
issueIdentifier 6
pageRange 816-821
publicationName Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
startingPage 816
bibliographicCitation Brodie BR. What anti-thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: how should the HORIZONS trial change current practice? Catheter Cardiovasc Interv. 2008 May 01;71(6):816–21. doi: 10.1002/ccd.21518. PMID: 18412079.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef722bf507abb5465c1112097b5b7ff0
date 2008-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1002/ccd.21518
https://pubmed.ncbi.nlm.nih.gov/18412079
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21369
https://portal.issn.org/resource/ISSN/1522-1946
https://portal.issn.org/resource/ISSN/1522-726X
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title What anti‐thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: How should the HORIZONS trial change current practice?
discusses http://id.nlm.nih.gov/mesh/M0155432
http://id.nlm.nih.gov/mesh/M0028424
http://id.nlm.nih.gov/mesh/M0021526
http://id.nlm.nih.gov/mesh/M0001380
http://id.nlm.nih.gov/mesh/M0021424
http://id.nlm.nih.gov/mesh/M0465835
http://id.nlm.nih.gov/mesh/M0001864
http://id.nlm.nih.gov/mesh/M0016224
http://id.nlm.nih.gov/mesh/M0018641
http://id.nlm.nih.gov/mesh/M0010187
http://id.nlm.nih.gov/mesh/M0008434
http://id.nlm.nih.gov/mesh/M0201405
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D018579
http://id.nlm.nih.gov/mesh/D015906Q000009
http://id.nlm.nih.gov/mesh/D002318Q000517
http://id.nlm.nih.gov/mesh/D005343Q000627
http://id.nlm.nih.gov/mesh/D009203Q000628
hasSubjectTerm http://id.nlm.nih.gov/mesh/D016032
http://id.nlm.nih.gov/mesh/D015607
http://id.nlm.nih.gov/mesh/D013988Q000031
http://id.nlm.nih.gov/mesh/D013917Q000037
http://id.nlm.nih.gov/mesh/D000925Q000627
http://id.nlm.nih.gov/mesh/D013927Q000517
http://id.nlm.nih.gov/mesh/D012107
http://id.nlm.nih.gov/mesh/D013927Q000209
http://id.nlm.nih.gov/mesh/D000077144
http://id.nlm.nih.gov/mesh/D019039Q000037
http://id.nlm.nih.gov/mesh/D013988Q000627
http://id.nlm.nih.gov/mesh/D006493Q000627
http://id.nlm.nih.gov/mesh/D010446Q000627
http://id.nlm.nih.gov/mesh/D005343Q000009
http://id.nlm.nih.gov/mesh/D002318Q000401
http://id.nlm.nih.gov/mesh/D002318Q000209
http://id.nlm.nih.gov/mesh/D006629
http://id.nlm.nih.gov/mesh/D015906Q000295
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D011994Q000627
http://id.nlm.nih.gov/mesh/D017410
http://id.nlm.nih.gov/mesh/D001241Q000627
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D006470Q000139
http://id.nlm.nih.gov/mesh/D009203Q000401
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6897
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6593
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.5
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16129704
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9207
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_77f2a7aa26c2bfc427c7b9e127e4fda9
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135830341

Total number of triples: 77.